Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study

References

• Scribner BH, Cole JJ, Ahmad S, Blagg CR. Why thrice weekly dialysis? Hemodial Int. 2004;8(2):188–192. doi:10.1111/j.1492-7535.2004.01094.x
   PubMedGoogle Scholar
• Rhee CM, Unruh M, Chen J, Kovesdy CP, Zager P, Kalantar-Zadeh K. Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial. 2013;26(6):720–727. doi:10.1111/sdi.12133
   PubMed Web of Science ®Google Scholar
• O’Hare AM, Wong SP, Yu MK, et al. Trends in the timing and clinical context of maintenance dialysis initiation. J Am Soc Nephrol. 2015;26(8):1975–1981. doi:10.1681/ASN.2013050531
   PubMed Web of Science ®Google Scholar
• Mathew AT, Obi Y, Rhee CM, Chou JA, Kalantar-Zadeh K. Incremental dialysis for preserving residual kidney function-does one size fit all when initiating dialysis? Semin Dial. 2018;31(4):343–352. doi:10.1111/sdi.12701
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Casino FG. Let us give twice-weekly hemodialysis a chance: revisiting the taboo. Nephrol Dial Transplant. 2014;29(9):1618–1620. doi:10.1093/ndt/gfu096
   PubMed Web of Science ®Google Scholar
• Obi Y, Streja E, Rhee CM, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a Cohort Study. Am J Kidney Dis. 2016;68(2):256–265. doi:10.1053/j.ajkd.2016.01.008
   PubMed Web of Science ®Google Scholar
• Wong J, Vilar E, Davenport A, Farrington K. Incremental haemodialysis. Nephrol Dial Transplant. 2015;30(10):1639–1648. doi:10.1093/ndt/gfv231
   PubMed Web of Science ®Google Scholar
• Tangvoraphonkchai K, Davenport A. Incremental hemodialysis - A European perspective. Semin Dial. 2017;30(3):270–276. doi:10.1111/sdi.12583
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang M, Li H, et al. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol. 2014;40(2):140–150. doi:10.1159/000365819
   PubMed Web of Science ®Google Scholar
• Kaja Kamal RM, Farrington K, Busby AD, et al. Initiating haemodialysis twice-weekly as part of an incremental programme may protect residual kidney function. Nephrol Dial Transplant. 2019;34(6):1017–1025. doi:10.1093/ndt/gfy321
   PubMed Web of Science ®Google Scholar
• Caria S, Cupisti A, Sau G, Bolasco P. The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol. 2014;15:172. doi:10.1186/1471-2369-15-172
   PubMed Web of Science ®Google Scholar
• Fernandez-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Perez J, Quereda-Rodriguez-Navarro C. Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Nefrologia. 2012;32(6):767–776. doi:10.3265/Nefrologia.pre2012.Jul.11517
   PubMed Web of Science ®Google Scholar
• Park JI, Park JT, Kim YL, et al. Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea. Nephrol Dial Transplant. 2017;32(2):355–363. doi:10.1093/ndt/gfw332
   PubMed Web of Science ®Google Scholar
• Chertow GM, Levin NW, Beck GJ, et al.; Group FHNT. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287–2300. doi:10.1056/NEJMoa1001593
   PubMed Web of Science ®Google Scholar
• Suri RS, Larive B, Sherer S, et al. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol. 2013;24(3):498–505. doi:10.1681/ASN.2012060595
   PubMed Web of Science ®Google Scholar
• Bieber B, Qian J, Anand S, et al. Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and quality of life in the China dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 2014;29(9):1770–1777. doi:10.1093/ndt/gft472
   PubMed Web of Science ®Google Scholar
• Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205–1213. doi:10.1681/ASN.V451205
   PubMed Web of Science ®Google Scholar
• Amorim LD, Cai J. Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol. 2015;44(1):324–333. doi:10.1093/ije/dyu222
   PubMed Web of Science ®Google Scholar
• Rhee CM, Obi Y, Mathew AT, Kalantar-Zadeh K. Precision medicine in the transition to dialysis and personalized renal replacement therapy. Semin Nephrol. 2018;38(4):325–335. doi:10.1016/j.semnephrol.2018.05.003
   PubMed Web of Science ®Google Scholar
• Murea M, Moossavi S, Garneata L, Kalantar-Zadeh K. Narrative review of incremental hemodialysis. Kidney Int Rep. 2020;5(2):135–148. doi:10.1016/j.ekir.2019.11.014
   PubMed Web of Science ®Google Scholar
• Obi Y, Kalantar-Zadeh K. Incremental and once- to twice-weekly hemodialysis: from experience to evidence. Kidney Int Rep. 2017;2(5):781–784. doi:10.1016/j.ekir.2017.07.006
   PubMed Web of Science ®Google Scholar
• Ocak G, Rotmans JI, Vossen CY, et al. Type of arteriovenous vascular access and association with patency and mortality. BMC Nephrol. 2013;14:79. doi:10.1186/1471-2369-14-79
   PubMed Web of Science ®Google Scholar
• Palmer BF, Henrich WL. Recent advances in the prevention and management of intradialytic hypotension. J Am Soc Nephrol. 2008;19(1):8–11. doi:10.1681/ASN.2007091006
   PubMed Web of Science ®Google Scholar
• Chang TI, Paik J, Greene T, et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011;22(8):1526–1533. doi:10.1681/ASN.2010101119
   PubMed Web of Science ®Google Scholar
• Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis. 2009;16(5):329–338. doi:10.1053/j.ackd.2009.06.009
   PubMed Web of Science ®Google Scholar
• Stracke S, Konner K, Kostlin I, et al. Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int. 2002;61(3):1011–1019. doi:10.1046/j.1523-1755.2002.00191.x
   PubMed Web of Science ®Google Scholar
• Obi Y, Rhee CM, Mathew AT, et al. Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol. 2016;27(12):3758–3768. doi:10.1681/ASN.2015101142
   PubMed Web of Science ®Google Scholar
• Shafi T, Jaar BG, Plantinga LC, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2010;56(2):348–358. doi:10.1053/j.ajkd.2010.03.020
   PubMed Web of Science ®Google Scholar
• van der Wal WM, Noordzij M, Dekker FW, et al. Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant. 2011;26(9):2978–2983. doi:10.1093/ndt/gfq856
   PubMed Web of Science ®Google Scholar
• Marants R, Qirjazi E, Grant CJ, Lee TY, McIntyre CW. Renal perfusion during hemodialysis: intradialytic blood flow decline and effects of dialysate cooling. J Am Soc Nephrol. 2019;30(6):1086–1095. doi:10.1681/ASN.2018121194
   PubMed Web of Science ®Google Scholar
• Malik J, Kudlicka J, Lachmanova J, et al. Tissue ischemia worsens during hemodialysis in end-stage renal disease patients. J Vasc Access. 2017;18(1):47–51. doi:10.5301/jva.5000630
   PubMed Web of Science ®Google Scholar
• Jofre R, Rodriguez-Benitez P, Lopez-Gomez JM, Perez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006;17(12 Suppl 3):S274–280. doi:10.1681/ASN.2006080926
   PubMed Web of Science ®Google Scholar
• Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant. 2018;33(suppl_3):iii35–iii40. doi:10.1093/ndt/gfy175
   PubMed Web of Science ®Google Scholar
• Costello-White R, Ryff CD, Coe CL. Aging and low-grade inflammation reduce renal function in middle-aged and older adults in Japan and the USA. Age (Dordr). 2015;37(4):9808. doi:10.1007/s11357-015-9808-7
   PubMedGoogle Scholar
• Kong JH, Davies MRP, Mount PF. Relationship between residual kidney function and symptom burden in haemodialysis patients. Intern Med J. 2021;51(1):52–61. doi:10.1111/imj.14775
   PubMed Web of Science ®Google Scholar